Pluxee: Q3 Down by 3.3%, Hindered by Brazilian Reform
Pluxee released its fiscal third quarter 2026 results on July 3, 2026. Over nine months, the group posted a total revenue organic growth of +2.7% reaching €967M. However, Q3 alone showed a contraction of -3.3% (€312M), reflecting the cumulative impact of regulatory reform in Brazil and economic weakening in continental Europe. The group still confirms its annual targets (revenue stability, slight EBITDA margin expansion), but anticipates persistent difficulties in the first half of 2027.
Nine Months of Growth Masking a Q3 Deterioration
Over the first nine months of fiscal year 2026, Pluxee recorded total revenues of €967M, up +2.7% organically from the same period in the previous year (€945M). This growth was primarily driven by a strong performance in the first six months, which helped cushion the slowdown in the third quarter. However, Q3 alone paints a less favorable picture. Total revenues reached €312M, marking a decline of -3.3% organically and almost stable in reported terms (+0.9%). Operating revenues decreased by -4.1% organically (€270M), while float revenues, more resilient, grew by +2.8% (€42M). This weakening is explained by two external factors: the implementation of the PAT 1 reform in Brazil (capping the merchant commission rate at 3.6%) directly impacted profitability, and the deteriorating macroeconomic environment in continental Europe indirectly affected the group's clients, limiting commercial dynamics.
Employee Benefits Hindered, Other Services in Decline
Within Q3, the Employee Benefits line generated total revenues of €279M, down -1.5% organically. Although the Business Volume Index (BVI) for Employee Benefits grew by +8.0% organically in Q3 (€5.2 billion), revenue conversion was hampered by the dual impact of the Brazilian reform and margin compression on existing portfolios. However, the performance over nine months remains more favorable, with an organic growth of +5.6% (€853M in total revenues) and a BVI Employee Benefits increase of +6.6% (€15.3 billion). This contrast shows that the nine-month base still carries the momentum from the earlier quarters. Conversely, Other Products & Services experienced a marked drop in Q3, with revenues down -15.5% organically (€34M). This contraction reflects the ongoing difficulties related to public benefit programs in continental Europe and transformation initiatives in the UK and the US. Over nine months, this line shows a decline of -14.5% organically (€114M).
Targets Confirmed Despite Persistent Regional Challenges
Bolstered by its performance over the first nine months, Pluxee confirmed its financial targets for fiscal year 2026 on July 3, 2026: stability of total revenues in organic growth and a slight expansion of the Recurring EBITDA margin. The group also targets an operational cash conversion (Recurring cash conversion) of about 80% on average for the period 2024-2026. However, the expected trajectory post-2026 reveals a certain caution. Pluxee anticipates that the measures and implementation schedules of the reform in Brazil will continue to impact financial accounts in the first fiscal semester of 2027. A return to sustainable and profitable growth is only expected from the second fiscal semester of 2027. This contrasting horizon poses a central question for investors: are the solidity of the nine months (growth +2.7%, BVI Employee Benefits +6.6%) and the group's execution capability sufficient to offset the regulatory inertia in Brazil and the macroeconomic weakness in continental Europe to maintain annual revenue stability? Q3 alone suggests that the margin for maneuver is narrowing.
